Frusedale 40 mg Oral Tablets
Introduction

Company name: Dechra Veterinary Products
Address: (A business unit of Dechra Pharmaceuticals PLC)
Cartmel Drive
Harlescott
Shrewsbury SY1 3TB
Telephone: 01743 441632
Fax: 01743 462111
Email: info@dechra-uk.com
Website: www.dechra-uk.com
Presentation
White, circular, biconvex, flat-faced tablets with bevelled edges and a breakline.
Each tablet contains Frusemide/Furosemide 40 mg.
Uses
Frusedale 40 mg oral tablets are for use in cats and dogs only, for the treatment of oedema associated with cardiac insufficiency, renal dysfunction and trauma.
In animals with pulmonary oedema of cardiac origin, combined therapy with other medicinal products may be indicated.
Frusemide is a potent diuretic with an onset of activity normally within 1 hour of administration and a duration of activity of approximately 4 hours.
Dosage and administration
For oral administration only. Cats and dogs above 4 kg bodyweight:
Dosage up to 5 mg/kg bodyweight, or one Frusedale 40 mg oral tablet per 8 kg bodyweight, 1 to 2 times daily with an interval of 6 to 8 hours between administrations.
For animals weighing between 4 and 8 kg, one half of one tablet should be administered. The tablets may be divided by breaking along the score line. For maintenance, the dosage should be reduced to 1-2 mg/kg per day.
Contra-indications, warnings, etc
Do not use in animals weighing less than 4 kg.
Do not use in animals with acute glomerular nephritis, renal failure with anuria, electrolyte deficiency disease or in animals that have received an overdosage of Digitalis.
Therapeutic efficacy may be impaired by increased intake of drinking water. Where the animal's condition permits, water intake should be restricted during treatment with Frusedale 40 mg oral tablets.
Monitoring of plasma Potassium levels is advisable during periods of prolonged treatment of combined therapy with cardiac glycosides. Potassium supplements may be necessary.
Do not use concurrently with aminoglycoside antibiotics or corticosteroids.
Concurrent administration with aminoglycoside antibiotics may result in ototoxicity.
Concurrent use of corticosteroids may increase the risk of hypokalaemia.
Concurrent administration with cephalosporin antibiotics may result in nephrotoxicity. Concurrent administration with sulphonamide antibacterials may result in sulphonamide allergy.
Frusedale 40 mg oral tablets may be used in pregnant or lactating animals.
If you notice any serious effects or other effects not mentioned in the leaflet, please inform your veterinary surgeon.
Operator warnings: Wear gloves or wash hands immediately after handling the tablets.
General precautions: For animal treatment only.
Pharmaceutical precautions
Do not store above 25°C. Protect from light. Keep out of the reach and sight of children.
Do not use after the expiry date stated on the label.
Disposal: Dispose of unused product and empty containers in accordance with guidance from your local waste regulation authority.
Legal category
POM-V
Packaging Quantities
Plastic containers of 1000 tablets.
Further information
To be supplied only on veterinary prescription.
UK authorised veterinary medicinal product.
Marketing authorisation number
Vm 10434/4033.